Daré Bioscience, Inc.DARENASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank15
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P15
Within normal range
vs 5Y Ago
-1x
Contraction
Streak
4 yr
Consecutive declineDecelerating
PeriodValue
2024-34.05%
2023-28.31%
2022-1.88%
202147.42%
2020143.03%
201933.24%
2018551.33%
2017-96.43%
20166.23%
2015120.42%